| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |